-
genomic and immunological assays to identify drivers of disease (such as lupus or cancer) and then utilize immune engineering and synthetic biology to identify novel treatments. Our lab has been recently
-
impact on pricing and commercial initiatives. Act as the contact with technology, publishing, and customer services teams on topics and initiatives related to individual OA pricing and discounts
-
team environment that encourages innovation and excellence in project execution. Stakeholder Engagement: Collaborate with internal stakeholders across departments (e.g. Publishing, Sales, Technology
-
, Chemistry, or Engineering. At least one year of postdoctoral experience is required. Experience, Knowledge, Skills, and Abilities: Postdoctoral experience. Published in major journals within the scope of PRX
-
, engineering or related areas with expertise including but not limited to the design and characterization or computational study of structural materials, metals and alloys, ceramics. Some postdoctoral research
-
culture, reproduction, or lentiviral technology. Candidates with less than one year of postdoctoral experience are preferred. Starting salary is US$66,300 per year plus benefits. Highly motivated and
-
including working with pathogenic (BSL-2) strains. Experience with immunoassays including flow cytometry, ELISAs, and preferably multiplexing technology like Luminex or MSD. Including analysis and statistics
-
inhibitors across the blood-brain barrier. Proof-of-principle in genetically engineered mouse models shows the power of this strategy. We now need dedicated scientists to help us realize the potential of gene
-
Francisco Join our team of dedicated scientists combining mouse genetic engineering, viral brain transduction, neurohistology, and basic biochemistry to understand what causes of dementia and to develop
-
. The vision for this position is to create opportunities to “translate” the technology from academia (benchtop experiment) to industry, crossing the line between early innovation and commercial readiness of new